Kerek Ádám, Román István, Szabó Ábel, Pézsa Nikolett Palkovicsné, Jerzsele Ákos
Department of Pharmacology and Toxicology, University of Veterinary Medicine, István utca 2, H-1078 Budapest, Hungary.
National Laboratory of Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health and Food Chain Safety, University of Veterinary Medicine, István utca 2, H-1078 Budapest, Hungary.
Vet Sci. 2025 Mar 2;12(3):217. doi: 10.3390/vetsci12030217.
The rapid proliferation of antimicrobial resistance has emerged as one of the most pressing animal and public health challenges of our time. Probiotics, extensively employed in human and veterinary medicine, are instrumental in maintaining a balanced microbiome and mitigating its disruption during antibiotic therapy. While their numerous benefits are well documented, probiotics also present potential risks, notably the capacity to harbor antimicrobial resistance genes. This genetic reservoir could contribute to the emergence and spread of antimicrobial resistance by facilitating the horizontal transfer of resistance genes to pathogenic bacteria within the gut. This review critically examines the presence of antimicrobial resistance genes in commonly used probiotic strains, explores the underlying mechanisms of resistance, and provides a balanced analysis of the benefits and risks associated with their use. By addressing these dual aspects, this paper highlights the need for vigilant evaluation of probiotics to preserve their therapeutic potential while minimizing public health risks.
抗菌药物耐药性的迅速扩散已成为我们这个时代最紧迫的动物和公共卫生挑战之一。益生菌广泛应用于人类医学和兽医学,有助于维持微生物群的平衡,并减轻抗生素治疗期间微生物群的破坏。虽然益生菌的诸多益处已得到充分证明,但它们也存在潜在风险,尤其是携带抗菌药物耐药基因的能力。这种基因库可能通过促进耐药基因在肠道内水平转移至病原菌,从而导致抗菌药物耐药性的产生和传播。本综述批判性地研究了常用益生菌菌株中抗菌药物耐药基因的存在情况,探讨了耐药的潜在机制,并对使用益生菌的益处和风险进行了全面分析。通过阐述这两个方面,本文强调了对益生菌进行审慎评估的必要性,以保留其治疗潜力,同时将公共卫生风险降至最低。